Varian Medical Systems SVP Unloads $49,470 in Stock (VAR)
Varian Medical Systems (NYSE:VAR) SVP John W. Kuo sold 582 shares of Varian Medical Systems stock on the open market in a transaction that occurred on Wednesday, July 9th. The stock was sold at an average price of $85.00, for a total value of $49,470.00. Following the completion of the transaction, the senior vice president now directly owns 14,061 shares in the company, valued at approximately $1,195,185. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of Varian Medical Systems (NYSE:VAR) traded up 0.39% during mid-day trading on Monday, hitting $85.47. The stock had a trading volume of 45,181 shares. Varian Medical Systems has a one year low of $69.02 and a one year high of $86.60. The stock has a 50-day moving average of $83.11 and a 200-day moving average of $82.00. The company has a market cap of $8.885 billion and a P/E ratio of 21.85.
Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $1.04 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.03 by $0.01. The company had revenue of $779.00 million for the quarter, compared to the consensus estimate of $772.84 million. During the same quarter last year, the company posted $1.04 earnings per share. Varian Medical Systems’s revenue was up 1.4% compared to the same quarter last year. Analysts expect that Varian Medical Systems will post $4.30 EPS for the current fiscal year.
A number of research firms have recently commented on VAR. Analysts at ISI Group initiated coverage on shares of Varian Medical Systems in a research note on Monday, June 30th. They set a “neutral” rating and a $90.00 price target on the stock. Separately, analysts at Morgan Stanley reiterated an “underweight” rating on shares of Varian Medical Systems in a research note on Wednesday, May 7th. They now have a $76.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note on Friday, April 25th. They now have a $83.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. Varian Medical Systems has an average rating of “Hold” and a consensus price target of $84.88.
Varian Medical Systems, Inc, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.